CBD Products Still Available in the EU Must Be Considered Unsafe, Say Researchers
A new preprint study from food chemists and public health experts at the Chemical and Veterinary Investigation Office Karlsruhe, Germany, provides a deeper look into the European Food Safety Authority's decision to halt novel food applications for CBD products.
ACS Laboratory Launches its Own Hemp Testing Panel
The panel will help the lab test hemp samples for 18 cannabinoids, 105 pesticides, 24 heavy metals, 55 potential residual solvents, 17 different microorganisms, and every required mycotoxin to detect parts per billion.
Curaleaf Pulls Thousands of Products Off Shelves After THC Labeling Switch
The multi-state operator has pulled tens of thousands of its products off of New York State shelves after the company switched to an unauthorized way of labeling product potency.
Training May Be Insufficient For Some Cannabis Dispensary Staff
A new study by researchers at Dana-Farber Cancer Institute suggests that despite a commitment by many dispensary workers to educate themselves about medical cannabis, dispensaries often prioritize sales skills over cannabis knowledge.
Institute for Cannabis Research Funds Study on Health Effects of Heavy Metal Inhalation in Cannabis Consumers
This is the first known human health risk assessment to evaluate the large number of heavy metals that may be present in cannabis flower, concentrates and vape devices.
SC Labs Completes Rebrand of National Cannabis and Hemp Testing Labs
The company now offers seamless testing services for cannabis across California, Michigan, Oregon, and Colorado, as well as hemp testing capabilities nationwide.
Research Suggests LSD May Enhance Learning and Memory
By studying human brain organoids — tissue cultures grown from stem cells that can mimic the developing brain — researchers have found that LSD regulates numerous processes related to neuroplasticity in the human brain.
Dual Action of Ketamine May Help Limit Addiction Risk
By demonstrating that ketamine induces only a brief increase in dopamine and does not alter neuronal communication, a team from the University of Geneva suggests that its therapeutic use may be safe.
Two Novel Chemical Entitities Show Early Potential for Significant Treatment Improvement in Depression
PSIL-001 and PSIL-002 show promising antidepressant effects without hallucinations while having improved learning and memory tendencies over a psilocybin mimic in a mouse model.
